DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home

Not Applicable

Completed

Conditions: Major Depressive Disorder

First Posted Date: 2007-07-23

Last Posted Date: 2013-09-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 9

Registration Number: NCT00505518

Locations: 🇺🇸
South Cove Manor, Boston, Massachusetts, United States
🇺🇸
Depression and Clinical Research Program at Massachusetts General Hospital, Boston, Massachusetts, United States

VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia

Phase 1

Completed

Conditions: Leukemia

First Posted Date: 2007-07-23

Last Posted Date: 2010-09-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 36

Registration Number: NCT00505700

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel/ Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Accelerated Mortality on Renal Replacement

Completed

Conditions: End Stage Renal Disease

First Posted Date: 2007-07-23

Last Posted Date: 2007-07-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 10018

Registration Number: NCT00505180

Two Approaches to Routine HIV Testing in a Hospital Emergency Department

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: Counselor-based HIV screening
Behavioral: Emergency staff member-based HIV screening

First Posted Date: 2007-07-18

Last Posted Date: 2012-07-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4855

Registration Number: NCT00502944

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism

Phase 3

Completed

Conditions: Autism

Interventions: Drug: Placebo
Drug: Atomoxetine

First Posted Date: 2007-07-09

Last Posted Date: 2017-08-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT00498173

Locations: 🇺🇸
Lurie Center - MassGeneral Hospital, Lexington, Massachusetts, United States
🇺🇸
Christian Sarkine Autism Treatment Center at Riley Hospital for Children, Indianapolis, Indiana, United States

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

Phase 1

Completed

Conditions: Kallmann Syndrome
Idiopathic Hypogonadotropic Hypogonadism
GnRH Deficiency

First Posted Date: 2007-06-29

Last Posted Date: 2022-07-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 27

Registration Number: NCT00493961

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders

Completed

Conditions: Puberty, Delayed
Puberty, Precocious
Hypogonadotropic Hypogonadism
Kallmann Syndrome
GnRH Deficiency

First Posted Date: 2007-06-29

Last Posted Date: 2022-06-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4042

Registration Number: NCT00494169

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Vitamin D Deficiency, Insulin Resistance and FGF-23

Not Applicable

Completed

Conditions: Vitamin D Deficiency

Interventions: Dietary Supplement: Ergocalciferol placebo
Dietary Supplement: Ergocalciferol

First Posted Date: 2007-06-26

Last Posted Date: 2018-05-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 92

Registration Number: NCT00491322

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Cisplatin
Drug: carboplatin

First Posted Date: 2007-06-06

Last Posted Date: 2017-08-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 86

Registration Number: NCT00483223

Locations: 🇺🇸
University of Alabama-Birmingham, Birmingham, Alabama, United States
🇺🇸
UCSF, San Francisco, California, United States
🇺🇸
Johns Hopkins University Medical Center, Baltimore, Maryland, United States

and more 7 locations

Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor

Phase 1

Withdrawn

Conditions: Kidney Insufficiency

Interventions: Drug: Rituximab

First Posted Date: 2007-05-22

Last Posted Date: 2023-10-23

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT00476515

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy